Call for applications: Continuous Patient Education (CoPE) Special call about Living & Ageing with HIV (Quality of Life)

12/10

We are pleased to announce that a call for applications for CoPE is now open. Please find below detailed information…

HIV Travel: The Global Database on HIV-specific Travel and Residence restrictions is updated

09/10

The Global Database on HIV-specific Travel & Residence Restrictions, a useful online tool regarding the cross-border mobility of people living…

M-Care 2018: Sharing the outcomes of the migrant advocates training programme

08/10

Today, Africa Advocacy Foundation (AAF) and the European AIDS Treatment Group (EATG) are launching the M-Care 2018 training programme report. Together…

ViiV Healthcare submits New Drug Application to US FDA for single-tablet, two-drug regimen of dolutegravir and lamivudine for treatment of HIV

18/10

Priority review voucher used with NDA submission with anticipated target action date of six months London, UK 17 October 2018…

Studies confirm long-term effectiveness of new single-tablet regimens

18/10

The newest once-daily, all-in-one HIV combination pills can maintain undetectable viral load for two years and counting, according to a…

Integrated support intervention improves engagement with HIV and methadone treatment among people who inject drugs

18/10

Fewer new HIV infections among injecting partners Providing information on how to navigate care pathways, psychosocial support, and immediate antiretroviral…

Call for applications: Continuous Patient Education (CoPE) Special call about Living & Ageing with HIV (Quality of Life)

12/10

We are pleased to announce that a call for applications for CoPE is now open. Please find below detailed information…

HIV Travel: The Global Database on HIV-specific Travel and Residence restrictions is updated

09/10

The Global Database on HIV-specific Travel & Residence Restrictions, a useful online tool regarding the cross-border mobility of people living…

M-Care 2018: Sharing the outcomes of the migrant advocates training programme

08/10

Today, Africa Advocacy Foundation (AAF) and the European AIDS Treatment Group (EATG) are launching the M-Care 2018 training programme report. Together…

ViiV Healthcare submits New Drug Application to US FDA for single-tablet, two-drug regimen of dolutegravir and lamivudine for treatment of HIV

18/10

Priority review voucher used with NDA submission with anticipated target action date of six months London, UK 17 October 2018…

Studies confirm long-term effectiveness of new single-tablet regimens

18/10

The newest once-daily, all-in-one HIV combination pills can maintain undetectable viral load for two years and counting, according to a…

Integrated support intervention improves engagement with HIV and methadone treatment among people who inject drugs

18/10

Fewer new HIV infections among injecting partners Providing information on how to navigate care pathways, psychosocial support, and immediate antiretroviral…